CA

Chanchal Ajmera

Active Director Director DIN 08331232
DIN 08331232 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Chanchal Ajmera

Data last updated:

Chanchal Ajmera is a Director at Generic Supermart India Private Limited (since 2019). The company operates in Pharma. Generic Supermart India Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 08331232
Primary Designation Director
Industry Pharma
First Appointment 14 Jan 2019
Oldest Company Age 7 yrs
Largest company Generic Supermart India Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20192019₹1.97 Cr (FY 2025)Active

Board colleagues of Chanchal Ajmera

Directorship timeline

Open interactive timeline →
Generic Supermart India Private Limited
Premium access

Shareholding and investment profile for Chanchal Ajmera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chanchal Ajmera

Chanchal Ajmera currently holds 1 directorship: Generic Supermart India Private Limited (Director, since 14 Jan 2019, revenue ₹1.97 Cr (FY 2025)).

Chanchal Ajmera was first appointed on 14 Jan 2019 as Director at Generic Supermart India Private Limited.

The current boards of Chanchal Ajmera's companies include Gyata Ajmera (Generic Supermart India Private Limited), Swati Ajmera (Generic Supermart India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available